Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach

PLoS ONE(2023)10.1371/journal.pone.0288039Source: DataRank Database

Identification of preclinical dementia according to ATN classification for stratified trial recruitment: A machine learning approach is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (43 grants)Impact (FWCI 1.07)OA: goldTopics (46)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Evgeniy Marinov ORCID,Simon Young ORCID,Sophia Lazarova ORCID,Деница Григорова ORCID,Dean Palejev ORCID

Live enrichment

PubMed:37856502 PMC:PMC10586674 OpenAlex:https://openalex.org/W4387771064

Alzheimer's Disease Neuroimaging Initiative

Grant: National Institutes of Health Grant U01 AG024904

DOD ADNI

Grant: Department of Defense award number W81XWH-12-2-0012

NIA NIH HHS

Grant: U01 AG024904

Canadian Institutes of Health Research

Grant: unidentified

unidentified

National Institutes of Health

Grant: 1U01AG024904-01

Alzheimers Disease Neuroimaging Initiative

European Commission

Grant: 857155

BiG DAta for SmarT SociEty

Biogen

Elan Pharmaceuticals, Inc.

Meso Scale Diagnostics, LLC.

Piramal Imaging

Alzheimer's Therapeutic Research Institute at the University of Southern California

Bristol-Myers Squibb Company

Fujirebio

Lundbeck

Merck & Co., Inc.

Pfizer Inc.

Takeda Pharmaceutical Company

Araclon Biotech

Cogstate

Johnson & Johnson Pharmaceutical Research & Development LLC.

National Institute on Aging

Northern California Institute for Research and Education

Transition Therapeutics

Lumosity

NeuroRx Research

Alzheimer's Association

EuroImmun

BioClinica, Inc.

CereSpir, Inc.

Eli Lilly and Company

GE Healthcare

IXICO Ltd.

Servier

Alzheimer's Drug Discovery Foundation

Eisai Inc.

Janssen Alzheimer Immunotherapy Research & Development, LLC.

National Institute of Biomedical Imaging and Bioengineering

Neurotrack Technologies

Novartis Pharmaceuticals Corporation

AbbVie

Canadian Institutes of Health Research

F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.

Foundation for the National Institutes of Health

FWCI

1.07

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

goldLicense: cc-by

journalhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0288039&type=printable

GOLDhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0288039&type=printable

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0288039&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0288039

journalhttps://doi.org/10.1371/journal.pone.0288039

Fields of Study

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsBiological Research and Disease StudiesMedicineComputer Science03 medical and health sciences0302 clinical medicineHumansBiomarkersAlzheimer DiseaseAmyloid beta-PeptidesMachine LearningAmyloidogenic ProteinsCognitive Dysfunctiontau Proteins

MeSH Terms

Machine LearningAlzheimer DiseaseHumansBiomarkersAmyloid beta-Peptidestau ProteinsAmyloidogenic ProteinsCognitive Dysfunction

Keywords

DementiaLogistic regressionRandom forestCohortMedicineArtificial intelligenceMachine learningNeurodegenerationSupport vector machineComputer scienceDiseasePathologyAmyloid beta-PeptidesScienceQRAmyloidogenic Proteinstau ProteinsAlzheimer DiseaseHumansCognitive DysfunctionBiomarkersResearch Article

Sustainable Development Goals

SDG 0: Life in Land